Skip to main content
SpringerLink
Log in

Fertility Preservation in Reproductive Age Women with Cancer

  • Invited Review Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Cancer may be detected at any age and could affect children, and reproductive age women as well. In recent years, cancer treatment has become less destructive and more specific. As a result, survival rates and quality of life following successful treatment have continuously improved. Cancer treatment typically involves surgery, chemo- or radiation therapy, or the combinations of these. These interventions often adversely affect the function of the reproductive organs. Chemo- and radiation therapy are known to be gonadotoxic. Survivors of oncologic therapy are typically rendered infertile primarily due to the loss of ovarian function. There are, however, several medical, surgical, and assisted reproductive technology options that could be and should be offered to those diagnosed with cancer and wish to maintain their fertility. Embryo cryopreservation has been available for decades and has been successfully applied for fertility preservation in women diagnosed with cancer. Recent advances in cryobiology have increased the efficacy of not just embryo but even oocyte and ovarian tissue freezing–thawing. Oocyte vitrification just like embryo cryopreservation requires the use of stimulation but does not require the patient to be in a stable relationship or accept the use of donor sperm. Ovarian tissue cryopreservation does not require stimulation and, following successful transplantation, provides the patient with the most eggs but is currently still considered experimental. This paper summarizes the various fertility-sparing medical, surgical and assisted reproductive technology options. It reviews the current status of embryo, oocyte, and ovarian tissue cryopreservation and discusses their risks and benefits.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, et al. Cancer Statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  2. Barber HR. The effect of cancer and its therapy upon fertility. Int J Fertil. 1981;26:250–9.

    CAS  PubMed  Google Scholar 

  3. Sankaranarayanan R, Gaffikin L, Jacob M et al. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89:S4–12.

    Article  PubMed  Google Scholar 

  4. Plante M, Renaud MC, Hoskins IA, et al. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol. 2005;98:3–10.

    Article  PubMed  Google Scholar 

  5. Ungar L, Palfalvi L, Hogg R, et al. Abdominal radical trachelectomy: a fertility-preserving option for women with early cervical cancer. BJOG. 2005;112:366–9.

    Article  PubMed  Google Scholar 

  6. Palfalvi L, Ungar L, Boyle DCM, et al. Announcement of healthy baby boy born following abdominal radical trachelectomy. Int J Gynecol Cancer. 2003;13:249.

    Article  Google Scholar 

  7. Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril. 1986;45:443–59.

    CAS  PubMed  Google Scholar 

  8. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003;188:367–70.

    Article  PubMed  Google Scholar 

  9. Bidzinski M, Lemieszczuk B, Zielinski J. Evaluation of the hormonal function and features of the ultrasound picture of transposed ovary in cervical cancer patients after surgery and pelvic irradiation. Eur J Gynaecol Oncol. 1993;14Suppl:77–80.

    Google Scholar 

  10. Gershenson DM, Miller AM, Champion VL, et al. Gynecologic oncology group. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study. J Clin Oncol. 2007;25:2792–7.

    Article  PubMed  Google Scholar 

  11. Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1–7.

    Article  PubMed  Google Scholar 

  12. Tinelli FG, Tinelli R, La Grotta F, et al. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol Scand. 2007;86:81–7.

    Article  CAS  PubMed  Google Scholar 

  13. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under the age 40. Obstet Gynecol. 1997;90:434–40.

    Article  CAS  PubMed  Google Scholar 

  14. Yamazawa K, Hirai M, Fujito A, et al. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod. 2007;22:1953–8.

    Article  CAS  PubMed  Google Scholar 

  15. Koskas M, Uzan J, Luton D, et al. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. Fertil Steril. 2014;101:785–94.

    Article  PubMed  Google Scholar 

  16. Posada MN, Kolp L, Garcia JE. Fertility options for female cancer patients: facts and fiction. Fertil Steril. 2001;75:647–53.

    Article  CAS  PubMed  Google Scholar 

  17. Blumenfeld Z, Avivi I, Eckman A, et al. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril. 2008;89:166–73.

    Article  CAS  PubMed  Google Scholar 

  18. Elgindy EA, El-Haieg DO, Khorshid OM, et al. Gonadotrophin suppression to prevent chemotherapy-induced ovarian damage. Obstet Gynecol. 2013;121:78–86.

    CAS  PubMed  Google Scholar 

  19. Bedaiwy MA, Abou-Setta AM, Desai N, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril. 2011;95:906–14.

    Article  CAS  PubMed  Google Scholar 

  20. Loren AW, Mangu PB, Beck LN, et al. American sociaty of clinical oncology. Fertility preservation for patients with cancer: Americal society of clinical oncology practice guideline update. J Clin Oncol. 2013;31:2500–10.

    Article  PubMed  Google Scholar 

  21. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature. 1983;305:707–9.

    Article  CAS  PubMed  Google Scholar 

  22. Abdel Hafez FF, Desai N, Abou-Setta AM, et al. Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-analysis. Reprod Biomed Online. 2010;20:209–22.

    Article  Google Scholar 

  23. Kuang Y, Hong Q, Chen Q, et al. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril. 2014;101:105–11.

    Article  CAS  PubMed  Google Scholar 

  24. Cakmak H, Katz A, Cedars MI, et al. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100:1673–80.

    Article  PubMed  Google Scholar 

  25. Oktay K, Buyuk E, Libertella M, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–53.

    Article  CAS  PubMed  Google Scholar 

  26. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26:2630–5.

    Article  CAS  PubMed  Google Scholar 

  27. Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1:884–6.

    Article  CAS  PubMed  Google Scholar 

  28. The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.

    Article  Google Scholar 

  29. Scaravelli G, Vigiliano V, Mayorga JM, et al. Analysis of oocyte cryopreservation in assisted reproduction: the Italian National Register data from 2005 to 2007. Reprod Biomed Online. 2010;21:496–500.

    Article  CAS  PubMed  Google Scholar 

  30. Smith GD, Serafini PC, Fioravanti J, et al. Prospective randomized comparison of huan oocyte cryopreservation with slow-freezing or vitrification. Fertil Steril. 2010;94:2088–95.

    Article  PubMed  Google Scholar 

  31. Almodin CG, Minguetti-Camara VC, Paixao CL, et al. Embryo development and gestation using fresh and vitrified oocytes. Hum Reprod. 2010;25:1192–8.

    Article  PubMed  Google Scholar 

  32. Rienzi L, Cobo A, Paffoni A, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod. 2012;27:1606–12.

    Article  PubMed  Google Scholar 

  33. Cobo A, Remohi J, Chang CC, et al. Oocyte cryopreservation for donor egg banking. Reprod Biomed Online. 2011;23:341–6.

    Article  CAS  PubMed  Google Scholar 

  34. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96:277–85.

    Article  PubMed  Google Scholar 

  35. Goldman KN, Noyes NL, Knopman JM, et al. Oocyte efficiency: does live birth rate differ when analyzing cryopreserved and fresh oocytes on a per-oocyte basis? Fertil Steril. 2013;100:712–7.

    Article  PubMed  Google Scholar 

  36. Di Pietro C, Vento M, Guglielmino MR, et al. Molecular profiling of human oocytes after vitrification strongly suggests that they are biologically comparable with freshly isolated gametes. Fertil Steril. 2010;94:2804–7.

    Article  PubMed  Google Scholar 

  37. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babied born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.

    Article  CAS  PubMed  Google Scholar 

  38. Levi Setti PE, Albani E, Morenghi E, et al. Comparative analysis of fetal and neonatal outcomes of pregnancies from fresh and cryopreserved/thawed oocytes in the same group of patients. Fertil Steril. 2013;100:396–401.

    Article  PubMed  Google Scholar 

  39. Chian RC, Uzelac PS, Nargund G. In vitro maturation of immature oocytes for fertility preservation. Fertil Steril. 2013;99:1173–81.

    Article  CAS  PubMed  Google Scholar 

  40. The Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101:1237–43.

    Article  Google Scholar 

  41. Donnez J, Dolemans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013;9:735–49.

    Article  CAS  PubMed  Google Scholar 

  42. Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril. 2010;93:762–8.

    Article  PubMed  Google Scholar 

  43. Oktay K, Economos K, Kan M, et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001;286:1490–3.

    Article  CAS  PubMed  Google Scholar 

  44. Bedaiwy MA, Falcone T. Whole ovary transplantation. Clin Obstet Gynecol. 2010;53:797–803.

    Article  PubMed  Google Scholar 

  45. Donnez J, Dolmans MM, Pellicier A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99:1503–13.

    Article  PubMed  Google Scholar 

  46. Salama M, Winkler K, Murach KF, et al. Female fertility loss and preservation: threats and opportunities. Ann Oncol. 2013;24:598–608.

    Article  CAS  PubMed  Google Scholar 

  47. Silber S, Kagawa N, Kuwayama M, et al. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94:2191–6.

    Article  PubMed  Google Scholar 

  48. Donnez J, Squifflet J, Pirard C, et al. Live birth after allografting of ovarian cortex between genetically non-identical sisters. Hum Reprod. 2011;26:1384–8.

    Article  PubMed  Google Scholar 

  49. Hilders CG, Baranski AG, Peters L, et al. Successful human ovarian autotransplantation to the upper arm. Cancer. 2004;101:2771–8.

    Article  PubMed  Google Scholar 

  50. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med. 2008;359:2617–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

Peter Kovacs declares that he has no conflict of interest.

Author information

Authors and Affiliations

  1. Kaali Institute, IVF Center, Istenhegyi ut 54/a, Budapest, 1125, Hungary

    Peter Kovacs

Authors
  1. Peter Kovacs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Kovacs.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovacs, P. Fertility Preservation in Reproductive Age Women with Cancer. J Obstet Gynecol India 64, 381–387 (2014). https://doi.org/10.1007/s13224-014-0626-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-014-0626-0

Keywords

Search

Navigation